Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.
Ana Maria OrbaiLaura C CoatesAtul DeodharPhilip S HelliwellChristopher T RitchlinEvan LeibowitzAlexa P KollmeierElizabeth C HsiaXie L XuShihong ShengYusang JiangYan LiuChenglong HanPublished in: The patient (2022)
GOV: Registration number, NCT03162796; Submission date 19 May 2017.